Extremity Implants Poised For Strong Growth As Ortho Market Evolves

Article preview from Medtech Insight - October, 2012 

In the joint reconstruction industry, the extremities market stands out as one area that is expected to continue to perform well, with newer and better technologies driving increased procedural growth and market penetration.

 Extremity Implants Poised For Strong Growth As Ortho Market Evolves

Article preview from Medtech Insight - October, 2012 

 As the adult orthopedic reconstruction market emerges from the doldrums and begins to gain steam, the extremities segment continues to stand out as an area of growth and opportunity. Growth in the overall extremities market remains in the high single-digits, at about 8% worldwide in 2012, driven in part by higher-priced reverse shoulders and total ankles.

According to BioMedGPS’ SmartTRAK Extremities module, US shoulder replacement revenues will grow nearly 10% to reach over $620 million during 2012, while the ankle replacement segment is expected to reach nearly $50 million with 12% to13% growth. Despite the implementation of US health care reform on the horizon, the market for extremity implants is expected to continue to experience healthy growth with the introduction of new and better technologies, expanded indications, and increased patient and physician awareness.

Neither procedural growth nor penetration of extremity technology for various conditions has yet reached a saturation point. For instance, BioMedGPS projects that more than 80,000 surgical procedures to treat thumb osteoarthritis (OA) will be performed in the US this year, but only about 3,500 of those will use a carpometacarpal (CMC) implant.

Continued...

To read this article in its entirety, purchase now, as a PDF and recieve it immediately via email. Or get it free when you subscribe to Medtech Insight Newsletter.

About Medtech Insight

Medtech Insight  newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc) impacting a wide range of  surgical and non-surgical clinical practices.